C Difficile

In vitro activity of fidaxomicin and combinations of fidaxomicin with other antibiotics against Clostridium perfringens strains isolated from dogs and cats - PubMed
In vitro activity of fidaxomicin and combinations of fidaxomicin with other antibiotics against Clostridium perfringens strains isolated from dogs and cats - PubMed
The results of this study demonstrate that fidaxomicin is highly effective against C. perfringens strains of canine and feline origin. Although fidaxomicin is currently considered a critically important antimicrobial that has not yet been licensed for veterinary use, we consider that the results rep …
·pubmed.ncbi.nlm.nih.gov·
In vitro activity of fidaxomicin and combinations of fidaxomicin with other antibiotics against Clostridium perfringens strains isolated from dogs and cats - PubMed
Engineered probiotics introduced to improve intestinal microecology for the treatment of chronic diseases: present state and perspectives - PubMed
Engineered probiotics introduced to improve intestinal microecology for the treatment of chronic diseases: present state and perspectives - PubMed
This review summarizes the application of synthetic biology in intestinal microecology-based therapeutics for major chronic diseases and discusses the opportunities and challenges in the above process, providing clinical possibilities of synthetic biology technology applied in microecological therap …
·pubmed.ncbi.nlm.nih.gov·
Engineered probiotics introduced to improve intestinal microecology for the treatment of chronic diseases: present state and perspectives - PubMed
Microbiome dynamics in rheumatic diseases - PubMed
Microbiome dynamics in rheumatic diseases - PubMed
A deeper comprehension of the microbiome's connection to rheumatism holds potential for enhancing disease diagnosis and treatment. Targeted therapeutic approaches, including probiotics, fecal microbiota transplantation, and combination therapies with medications, offer promising avenues for disease …
·pubmed.ncbi.nlm.nih.gov·
Microbiome dynamics in rheumatic diseases - PubMed
Gut Frailty: Its Concept and Pathogenesis - PubMed
Gut Frailty: Its Concept and Pathogenesis - PubMed
Although the concept of gut frailty has not yet gained widespread recognition, we hope to propose more practical screening methods, diagnostic approaches, and specific interventions in the future.
·pubmed.ncbi.nlm.nih.gov·
Gut Frailty: Its Concept and Pathogenesis - PubMed
Unraveling Physical Interactions of Clostridioides difficile with Phage and Phage-Derived Proteins Using In Vitro and Whole-Cell Assays - PubMed
Unraveling Physical Interactions of Clostridioides difficile with Phage and Phage-Derived Proteins Using In Vitro and Whole-Cell Assays - PubMed
Physical interactions between bacteria and phages provide valuable insights into the mechanisms of phage infection and may provide information on the use of phages as a therapeutic approach. In this study, we employed a combination of in vitro and whole-cell assays to examine the interactions betwee …
·pubmed.ncbi.nlm.nih.gov·
Unraveling Physical Interactions of Clostridioides difficile with Phage and Phage-Derived Proteins Using In Vitro and Whole-Cell Assays - PubMed
Revised Model for the Type A Glycan Biosynthetic Pathway in Clostridioides difficile Strain 630Δ erm Based on Quantitative Proteomics of cd0241- cd0244 Mutant Strains - PubMed
Revised Model for the Type A Glycan Biosynthetic Pathway in Clostridioides difficile Strain 630Δ erm Based on Quantitative Proteomics of cd0241- cd0244 Mutant Strains - PubMed
The bacterial flagellum is involved in a variety of processes including motility, adherence, and immunomodulation. In the Clostridioides difficile strain 630Δerm, the main filamentous component, FliC, is post-translationally modified with an O-linked Type A glycan structure. Thi …
·pubmed.ncbi.nlm.nih.gov·
Revised Model for the Type A Glycan Biosynthetic Pathway in Clostridioides difficile Strain 630Δ erm Based on Quantitative Proteomics of cd0241- cd0244 Mutant Strains - PubMed
Company Who Developed Oral Live Biotherapeutic Reports Earnings
Company Who Developed Oral Live Biotherapeutic Reports Earnings
Seres Therapeutics reported its financials recently including the performance of it therapy, Vowst, as well as updates on its business and one of its investigational therapies.
·news.google.com·
Company Who Developed Oral Live Biotherapeutic Reports Earnings
Pleiotropic effects of Mentha longifolia L. extract on the regulation of genes involved in inflammation and apoptosis induced by Clostridioides difficile ribotype 001 - PubMed
Pleiotropic effects of Mentha longifolia L. extract on the regulation of genes involved in inflammation and apoptosis induced by Clostridioides difficile ribotype 001 - PubMed
Our results demonstrated for the first time the antimicrobial, anti-inflammatory, and anti-apoptotic effects of M. longifolia extract on C. difficile RT001 and its Tox-S. However, further research is needed to evaluate the potential application of M. longifolia extract on CDI tr …
·pubmed.ncbi.nlm.nih.gov·
Pleiotropic effects of Mentha longifolia L. extract on the regulation of genes involved in inflammation and apoptosis induced by Clostridioides difficile ribotype 001 - PubMed
The pan-microbiome profiling system Taxa4Meta identifies clinical dysbiotic features and classifies diarrheal disease - PubMed
The pan-microbiome profiling system Taxa4Meta identifies clinical dysbiotic features and classifies diarrheal disease - PubMed
Targeted metagenomic sequencing is an emerging strategy to survey disease- specific microbiome biomarkers for clinical diagnosis and prognosis. However, this approach often yields inconsistent or conflicting results due to inadequate study power and sequencing bias. We introduce Taxa4Meta, a bioinfo …
·pubmed.ncbi.nlm.nih.gov·
The pan-microbiome profiling system Taxa4Meta identifies clinical dysbiotic features and classifies diarrheal disease - PubMed
Investigational non-antibiotic therapeutics for infections in hematopoietic cell transplant recipients and patients with hematologic malignancies receiving cellular therapies - PubMed
Investigational non-antibiotic therapeutics for infections in hematopoietic cell transplant recipients and patients with hematologic malignancies receiving cellular therapies - PubMed
In the age of progressive antimicrobial resistance and increased difficulty combating infections in immunocompromised hosts, there has been renewed interest in the use of nontraditional therapeutics for infections. Herein, we review the use of investigational non-pharmaceutical anti-infective agents …
·pubmed.ncbi.nlm.nih.gov·
Investigational non-antibiotic therapeutics for infections in hematopoietic cell transplant recipients and patients with hematologic malignancies receiving cellular therapies - PubMed
Therapeutic Approach Targeting Gut Microbiome in Gastrointestinal Infectious Diseases - PubMed
Therapeutic Approach Targeting Gut Microbiome in Gastrointestinal Infectious Diseases - PubMed
While emerging evidence highlights the significance of gut microbiome in gastrointestinal infectious diseases, treatments like Fecal Microbiota Transplantation (FMT) and probiotics are gaining popularity, especially for diarrhea patients. However, the specific role of the gut microbiome in different …
·pubmed.ncbi.nlm.nih.gov·
Therapeutic Approach Targeting Gut Microbiome in Gastrointestinal Infectious Diseases - PubMed
Understanding the Gut-Brain Axis and Its Therapeutic Implications for Neurodegenerative Disorders - PubMed
Understanding the Gut-Brain Axis and Its Therapeutic Implications for Neurodegenerative Disorders - PubMed
The gut-brain axis (GBA) is a complex bidirectional communication network connecting the gut and brain. It involves neural, immune, and endocrine communication pathways between the gastrointestinal (GI) tract and the central nervous system (CNS). Perturbations of the GBA have been reported in many n …
·pubmed.ncbi.nlm.nih.gov·
Understanding the Gut-Brain Axis and Its Therapeutic Implications for Neurodegenerative Disorders - PubMed
Microbiota-Gut-Brain Axis and Antidepressant Treatment - PubMed
Microbiota-Gut-Brain Axis and Antidepressant Treatment - PubMed
In the treatment of depressive disorders, conventional antidepressant therapy has been the mainstay of clinical management, along with well-established nonpharmacological interventions such as various kinds of psychotherapy. Over the last 2 decades, there has been considerable interest in the role o …
·pubmed.ncbi.nlm.nih.gov·
Microbiota-Gut-Brain Axis and Antidepressant Treatment - PubMed
Clostridioides difficile MreE (PBP2) variants facilitate clinical disease during cephalosporin exposures - PubMed
Clostridioides difficile MreE (PBP2) variants facilitate clinical disease during cephalosporin exposures - PubMed
Cephalosporins are the most common triggers of healthcare-associated Clostridioides difficile infections (CDI). Here, we confirm gene-level drivers of cephalosporin resistance and their roles in promoting disease. Genomic-epidemiologic analyses of 306 C. difficile isolates from a hospi …
·pubmed.ncbi.nlm.nih.gov·
Clostridioides difficile MreE (PBP2) variants facilitate clinical disease during cephalosporin exposures - PubMed
The Role of Antimicrobial Stewardship in Outpatient, Hospital Settings
The Role of Antimicrobial Stewardship in Outpatient, Hospital Settings
In this video roundtable discussion, Jaspal Singh, MD, MHA, MHS, interviews Dr Lisa Davidson, MD, and Ryan Maves, MD, about the importance of antimicrobial stewardship, fighting antimicrobial resistance, diagnostic stewardship, minimizing toxicity, and maximizing infection control.
·news.google.com·
The Role of Antimicrobial Stewardship in Outpatient, Hospital Settings
What Specialties are Using Live Biotherapeutic Products?
What Specialties are Using Live Biotherapeutic Products?
With the FDA approval of 2 of these products, which are indicated for recurrent Clostridioides difficile infection (CDI), a study reviewed which types of clinicians are prescribing them and the protocols in using them.
·contagionlive.com·
What Specialties are Using Live Biotherapeutic Products?
The pH-responsive SmrR-SmrT system modulates C. difficile antimicrobial resistance, spore formation, and toxin production - PubMed
The pH-responsive SmrR-SmrT system modulates C. difficile antimicrobial resistance, spore formation, and toxin production - PubMed
C. difficile is a mammalian pathogen that colonizes the large intestine and produces toxins that lead to severe diarrheal disease. C. difficile is a major threat to public health due to its intrinsic resistance to antimicrobials and its ability to form dormant spores that are easily sp …
·pubmed.ncbi.nlm.nih.gov·
The pH-responsive SmrR-SmrT system modulates C. difficile antimicrobial resistance, spore formation, and toxin production - PubMed